Implications of new understandings of gliomas in children and adults with NF1: Report of a consensus conference
Document Type
Journal Article
Publication Date
6-9-2020
Journal
Neuro-Oncology
Volume
22
Issue
6
DOI
10.1093/neuonc/noaa036
Keywords
gliomas; immunotherapy; molecular-targeted therapy; neurofibromatosis type 1; pilocytic astrocytomas
Abstract
Gliomas are the most common primary central nervous system tumors occurring in children and adults with neurofibromatosis type 1 (NF1). Over the past decade, discoveries of the molecular basis of low-grade gliomas (LGGs) have led to new approaches for diagnosis and treatments. However, these new understandings have not been fully applied to the management of NF1-associated gliomas. A consensus panel consisting of experts in NF1 and gliomas was convened to review the current molecular knowledge of NF1-associated low-grade "transformed" and high-grade gliomas; insights gained from mouse models of NF1-LGGs; challenges in diagnosing and treating older patients with NF1-associated gliomas; and advances in molecularly targeted treatment and potential immunologic treatment of these tumors. Next steps are recommended to advance the management and outcomes for NF1-associated gliomas.
APA Citation
Packer, R., Iavarone, A., Jones, D., Blakeley, J., Bouffet, E., Fisher, M., Hwang, E., Hawkins, C., Kilburn, L., MacDonald, T., Pfister, S., Rood, B., Rodriguez, F., Tabori, U., Ramaswamy, V., Zhu, Y., Fangusaro, J., Johnston, S., & Gutmann, D. (2020). Implications of new understandings of gliomas in children and adults with NF1: Report of a consensus conference. Neuro-Oncology, 22 (6). http://dx.doi.org/10.1093/neuonc/noaa036
